Evogene (NASDAQ:EVGN) Now Covered by StockNews.com

StockNews.com began coverage on shares of Evogene (NASDAQ:EVGN) in a research note published on Wednesday. The firm issued a sell rating on the biotechnology company’s stock.

Separately, Alliance Global Partners reissued a “buy” rating on shares of Evogene in a research report on Friday, March 7th.

Evogene Stock Performance

Shares of NASDAQ:EVGN opened at $1.34 on Wednesday. The firm’s 50 day simple moving average is $1.49 and its 200-day simple moving average is $1.87. The firm has a market cap of $7.16 million, a PE ratio of -0.30 and a beta of 1.28. Evogene has a one year low of $1.20 and a one year high of $9.00.

Evogene (NASDAQ:EVGN) last released its quarterly earnings data on Thursday, March 6th. The biotechnology company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.72) by $0.78. The firm had revenue of $1.61 million for the quarter, compared to the consensus estimate of $3.63 million. Evogene had a negative net margin of 314.43% and a negative return on equity of 109.05%. During the same period last year, the firm earned ($1.30) earnings per share.

Institutional Trading of Evogene

A hedge fund recently bought a new stake in Evogene stock. Jane Street Group LLC purchased a new stake in Evogene Ltd. (NASDAQ:EVGN) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 21,345 shares of the biotechnology company’s stock, valued at approximately $40,000. Jane Street Group LLC owned approximately 0.40% of Evogene as of its most recent SEC filing. Institutional investors own 10.40% of the company’s stock.

About Evogene

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.